Morningstar (MORN) analyst forecast and price target
Analyst forecast
Consensus of 3 analyst ratings
Recent analyst ratings
| Firm | Action | Rating | Price target | Date |
|---|---|---|---|---|
| UBS | Maintained | Buy | $260.00 from $280.00 | Jul 7, 2026 |
| BMO Capital | Maintained | Outperform | $193.00 from $257.00 | Feb 17, 2026 |
| UBS | Maintained | Buy | $320.00 from $350.00 | Oct 30, 2025 |
| BMO Capital | Maintained | Outperform | $355.00 from $339.00 | May 12, 2025 |
| BMO Capital | Maintained | Outperform | $370.00 from $387.00 | Mar 3, 2025 |
| Redburn Atlantic | Downgraded | Buy → Neutral | $340.00 | Oct 9, 2024 |
| UBS | Initiated Coverage | Buy | $390.00 | Oct 8, 2024 |
| BMO Capital | Maintained | Outperform | $352.00 | Aug 28, 2024 |
| BMO Capital | Initiated Coverage | Outperform | $352.00 | Aug 12, 2024 |
| Redburn Atlantic | Upgraded | Neutral → Buy | $320.00 | Oct 30, 2023 |
Frequently asked questions
Is MORN a buy, sell, or hold?
Analysts covering Morningstar currently average a Buy rating: 2 buy, 1 hold and 0 sell, from 3 analysts. Ratings reflect analyst opinion, not investment advice.
What is the latest analyst rating on MORN?
On Jul 7, 2026, UBS maintained Morningstar at Buy with a price target of $260.00.
Analyst ratings and price targets are the opinions of third-party research firms, not of Light Horse Securities. They are estimates about an uncertain future, are frequently wrong, and are neither a recommendation nor a prediction of actual results.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.